ANCHIANO THERAPEUTICS LTD
Market Data Charts Historical Prices Statistics Profile Analysis & Rating Disclosures
www.anchiano.com
   Issuer No.   
Corporate No.
   Market Cap (19/03/2019)   
   1600   
   514672625   
    144,586 NIS thousands   
   TASE Supersector
   TASE Sector   
   TASE Subsector   
   Indices   
   High-Tech   
   Biomed   
   Biotechnology   
   TA-Biomed Index, TA-Growth, TA Global-BlueTech, TA-AllShare, TA Tech - Elite, Additional Indices   
  Contact Details :
  Phone : 02-5486555
  Fax : 02-5486550
  AVRAHAM.HAMPEL@ANCHIANO.COM
   Interested Parties:
   Interested Parties:
List of Interested Parties  >
List of Securities  >
Indices  >
Index Adjusted Data for Company Securities  >
Financial Statements – Key Data (NIS thousands) **
 Yearly 2018Yearly 2017
Balance Sheet
Total Assets
47,127
7,236
Current Assets
28,174
6,428
Non Current Assets
18,953
808
Shareholders Equity
-4,085
-2,113
Of which Minority Interest
0
0
Current Liabilities
0
9,349
Long-Term Liabilities
51,213
0
Profit & Loss Statement
Revenues
---
0
Gross Profit
0
0
Operating Income
-48,889
-33,714
Income Before Tax
-47,442
-34,074
Net Income
-49,770
-35,231
Income Attributable to Shareholders
-49,770
-35,231
Earnings per Share
-3.94
-0.39
Additional Data
Dividends
0
0
Net cash flow generated by operating activities
-55,261
-30,587
Financial Ratios
Market to book value
---
---
Price-Earning Ratio
Loss
---
Equity-Assets Ratio
---
---
Return on Equity
Loss
Loss
 Export Table Data 
Note: The financial statements data have been obtained from A-Online and they were compiled and processed by it. The data have not been examined or audited by the Stock Exchange and they are presented as given to the Stock Exchange by A-Online.
The binding data are those appearing in the financial statements published by the Company. Without derogating from the provisions of the use agreement , the Stock Exchange is not liable for any fault, error, mistake or inaccuracy in the data presented. Financial statements published in foreign currency are translated to NIS according to the exchange rate at the date of the financial statements.
Financial Ratios: Market Capitalization – as of end of previous trading day; Net income – attributable to the Shareholders (Trailing Twelve Months); Shareholders' Equity- attributable to the Shareholders (average 12 months start and end of period).